한글목차

세계 약물 용출 스텐트 시장의 미래는 유망하며, 관상동맥질환 및 말초동맥질환 시장에 기회가 있습니다. 세계 약물 용출 스텐트 시장은 2025-2031년 6.3%의 연평균 복합 성장률(CAGR)로 2031년에는 약 137억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 전 세계 노인 인구 증가와 심혈관 질환 발생률 증가입니다.

• Lucintel의 예측에 따르면, 코팅 유형별로는 고분자 코팅이 그 효과와 적응성이 입증된 만큼 예측 기간 동안에도 큰 비중을 차지할 것으로 보입니다.
• 용도별 시장에서는 전 세계 관상동맥 질환의 유병률 증가로 인해 관상동맥 질환이 계속해서 큰 비중을 차지할 것으로 예측됩니다.
• 지역별로 보면, 북미는 의료 인프라가 발달하고 첨단 의료기술이 널리 보급되어 있어 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 보입니다.

약물 용출 스텐트 시장의 전략적 성장 기회

DES 시장은 주요 응용 분야에서 다양한 전략적 기회를 통해 성장하고 있습니다. 이러한 기회를 파악하고 활용하면 시장에서의 입지를 강화하고 환자 치료 결과를 개선할 수 있습니다.

• 신흥 시장 진출: 아시아태평양 및 라틴아메리카 등 신흥 시장은 심혈관 질환 발병률 증가와 의료 투자 증가로 인해 큰 성장 기회가 되고 있습니다. 이 지역에서 시장 입지를 확대하면 매출 성장을 가속하고 첨단 스텐트 기술에 대한 접근성을 높일 수 있습니다.
• 차세대 스텐트 개발: 약물 전달 시스템 개선, 얇은 스트럿, 생분해성 재료 등을 갖춘 차세대 DES에 대한 투자는 큰 성장 잠재력을 가지고 있습니다. 이러한 기술 혁신은 현재의 한계를 극복하고 스텐트 치료의 효과와 안전성을 향상시켜 임상의와 환자 모두를 끌어들일 수 있습니다.
• 디지털 헬스 기술 통합: 원격 모니터링 및 데이터 분석과 같은 디지털 헬스 기술을 DES 치료 프로토콜에 통합하여 환자 관리 및 결과를 개선할 수 있습니다. 이러한 기술을 통해 스텐트 성능과 환자의 순응도를 더 잘 추적할 수 있어 보다 효과적인 치료로 이어질 수 있습니다.
• 개인맞춤형 의료의 중요성: 개인맞춤형 의료에 대한 관심이 높아짐에 따라 환자 개개인의 필요에 따라 맞춤형 DES 솔루션을 개발할 수 있는 기회가 생겼습니다. 유전자 및 임상 데이터를 활용하여 제조업체는 최적화된 약물 처방과 스텐트 설계를 통해 치료 효과를 높일 수 있습니다.
• 영상 진단의 발전: OCT, 혈관 내 초음파 등 첨단 영상 기술을 DES에 접목하여 스텐트 삽입 및 배치의 정확도를 향상시킬 수 있습니다. 이를 통해 혈관 상태를 보다 정확하게 평가하고, 스텐트 크기를 보다 정확하게 결정할 수 있어 환자의 예후를 개선할 수 있습니다.

DES 시장의 전략적 성장 기회는 기술 발전, 시장 확대, 개인화 접근 방식 등으로 인해 발생합니다. 이해관계자들은 이러한 기회를 활용하여 시장에서의 입지를 강화하고 환자 치료 개선에 기여할 수 있습니다.

약물 용출 스텐트 시장 성장 촉진요인 및 과제

DES 시장은 성장 궤도에 영향을 미치는 다양한 촉진요인 및 과제에 의해 형성되고 있습니다. 기술 발전, 경제적 요인, 규제 문제는 시장 역학을 결정하고 이해관계자의 전략에 영향을 미치는 데 중요한 역할을 합니다.

약물 용출 스텐트 시장을 견인하는 요인으로는 다음과 같은 것들이 있습니다.

• 기술 발전: 약물 전달 시스템, 생분해성 소재를 개선한 차세대 DES 등 스텐트 기술의 혁신이 시장 성장의 원동력이 되고 있습니다. 이러한 발전은 스텐트의 효과와 안전성을 향상시켜 환자의 예후를 개선하고 채택률을 높일 수 있습니다.
• 심혈관 질환의 유병률 증가: 전 세계 심혈관 질환의 유병률 증가는 DES 시장의 중요한 촉진요인입니다. 환자 수 증가는 효과적인 치료 옵션에 대한 높은 수요를 창출하고 DES 기술의 성장을 가속합니다.
• 규제 지원 및 혁신 : 규제 프로세스의 간소화와 혁신적인 의료기기에 대한 지원은 새로운 DES 기술의 신속한 승인과 시장 진입을 촉진하고 있습니다. 이러한 규제 환경은 지속적인 연구개발을 장려하고 시장 확대를 촉진합니다.
• 의료비 지출 증가: 의료비 지출 증가와 첨단 의료 기술에 대한 투자가 DES 시장 성장에 기여하고 있습니다. 심혈관 치료에 대한 예산 증가는 최첨단 스텐트 기술의 채택을 가능하게 하고 있습니다.
• 개인 맞춤형 의료에 대한 관심 증가: 개인 맞춤형 의료와 맞춤형 치료 접근 방식에 대한 강조가 DES의 기술 혁신을 촉진하고 있습니다. 개별 환자 프로파일에 따른 맞춤형 스텐트 설계 및 약물 처방은 치료 결과와 시장 수요를 향상시킬 수 있습니다.

약물 용출 스텐트 시장의 과제는 다음과 같습니다.

• 고급 DES의 높은 비용: 고급 DES 기술의 높은 비용은 특히 신흥 시장에서 접근성과 경제성을 제한할 수 있습니다. 이 문제는 특히 비용에 민감한 지역에서 시장 침투율과 채택률에 영향을 미칠 수 있습니다.
• 규제 및 상환 장애물: 복잡한 규제 요건과 상환 문제는 시장 진입 및 확장에 어려움을 겪을 수 있습니다. 이러한 장애물을 극복하기 위해서는 많은 자원과 전문 지식이 필요하며, 새로운 DES 기술의 도입 속도와 용이성에 영향을 미칠 수 있습니다.
• 경쟁과 시장 포화: DES 제조업체와 제품 수 증가는 시장 포화와 경쟁의 심화로 이어질 수 있습니다. 경쟁이 심화되는 상황에서 제품을 차별화하고 시장 점유율을 유지하는 것은 기업에게 어려운 일입니다.

기술 발전과 심혈관 질환 증가와 같은 시장 성장 촉진요인이 DES 시장을 발전시키고 있습니다. 그러나 지속적인 성장과 시장 개척을 위해서는 높은 비용과 규제 장벽과 같은 과제를 해결해야 합니다. 이러한 요인의 균형을 맞추는 것이 DES 시장의 미래를 형성하는 데 매우 중요합니다.

목차

제1장 주요 요약

제2장 세계의 약물 용출 스텐트 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 약물 용출 스텐트 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 약물 용출 스텐트 시장 : 코팅 유형별
  • 폴리머계 코팅
  • 폴리머 프리 코팅
• 세계의 약물 용출 스텐트 시장 : 용도별
  • 관상동맥 질환
  • 말초동맥 질환

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 약물 용출 스텐트 시장 : 지역별
• 북미의 약물 용출 스텐트 시장
• 유럽의 약물 용출 스텐트 시장
• 아시아태평양의 약물 용출 스텐트 시장
• 기타 지역의 약물 용출 스텐트 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 약물 용출 스텐트 시장 성장 기회 : 코팅 유형별
  • 세계의 약물 용출 스텐트 시장 성장 기회 : 용도별
  • 세계의 약물 용출 스텐트 시장 성장 기회 : 지역별
• 세계 약물 용출 스텐트 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 약물 용출 스텐트 시장 생산능력 확대
  • 세계 약물 용출 스텐트 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Boston Scientific
• Medtronic
• Abbott Laboratories
• Biosensors
• Biotronik
• Lepu Medical Technology
• Terumo Medical
• Cook Medical
• Shandong JW Medical Systems
• B.Braun

영문목차

The future of the global drug-eluting stent market looks promising, with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $13.7 billion by 2031, with a CAGR of 6.3% from 2025 to 2031. The major drivers for this market are the increasing global elderly population and rising incidence of cardiovascular disorders.

• Lucintel forecasts that, within the coating type category market, polymer-based coatings will remain a larger segment over the forecast period due to their proven effectiveness and adaptability.
• Within the application category market, coronary artery disease will remain a larger segment due to the increasing global incidence of coronary artery disease.
• In terms of regions, North America will remain the largest region over the forecast period due to the presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Gain valuable insights for your business decisions with our 150+ page report.

Emerging Trends in the Drug-Eluting Stent Market

Emerging trends in the DES market reflect advancements in technology, changing patient demographics, and evolving healthcare needs. These trends are influencing product development, market dynamics, and treatment outcomes, providing insights into the future of cardiovascular interventions.

• Biodegradable Stents: Biodegradable stents are gaining traction due to their ability to dissolve over time, reducing the risk of long-term complications and eliminating the need for permanent implants. These stents offer the advantage of restoring natural vessel function after degradation, which is beneficial for patients with complex cardiovascular conditions.
• Advanced Drug Delivery Systems: New DES technologies feature improved drug delivery systems that enhance the precision and efficacy of medication release. This includes the development of stents with controlled drug elution rates and novel drug combinations, which help reduce restenosis and improve overall treatment outcomes.
• Personalized Medicine: The trend toward personalized medicine in DES involves tailoring stent designs and drug formulations to individual patient profiles. Advances in genomics and diagnostics are allowing for more customized treatment approaches, potentially leading to better outcomes and reduced adverse events.
• Integration of Imaging Technologies: The integration of advanced imaging technologies, such as optical coherence tomography (OCT), is enhancing the precision of stent placement and deployment. These technologies provide detailed insights into vessel characteristics, allowing for more accurate stent sizing and placement.
• Regulatory Changes: Regulatory bodies are adopting more flexible and accelerated approval processes for innovative DES technologies. This includes streamlined pathways for clinical trials and faster market access, which encourage the development and availability of new stent options.

These emerging trends are reshaping the DES market by driving innovation, improving patient outcomes, and increasing market accessibility. As technology advances and regulatory landscapes evolve, the DES market will continue to grow and adapt to meet the needs of patients and healthcare providers.

Recent Developments in the Drug-Eluting Stent Market

Recent developments in the DES market are characterized by technological innovations, regulatory updates, and evolving healthcare needs. These changes are transforming the landscape of cardiovascular treatments, improving patient outcomes, and driving market growth.

• Introduction of Next-Generation Stents: Next-generation DES featuring thinner struts and improved drug coatings are now available. These advancements contribute to reduced restenosis rates and enhanced biocompatibility, leading to better long-term outcomes and patient satisfaction.
• Biodegradable Stent Technologies: The development of biodegradable stents, which gradually dissolve over time, has become a significant trend. These stents reduce the risk of chronic complications associated with permanent implants and restore natural vessel function, offering a promising alternative to traditional DES.
• Enhanced Drug Delivery Systems: Advances in drug delivery technologies, such as controlled-release mechanisms and novel drug formulations, are improving the efficacy of DES. These innovations ensure more precise and effective medication delivery, reducing the likelihood of restenosis and stent thrombosis.
• Increased Focus on Personalized Medicine: Personalized medicine is gaining traction, with DES being tailored to specific patient needs based on genetic and clinical profiles. This approach aims to optimize treatment outcomes by addressing individual variations in disease and response to therapy.
• Regulatory Changes and Market Access: Regulatory bodies are adopting more streamlined approval processes for innovative DES technologies. These changes facilitate quicker market entry for new stent designs and improve access to advanced treatment options for patients.

These recent developments are driving significant changes in the DES market, leading to improved patient outcomes and expanding market opportunities. As technology and regulations continue to evolve, the DES market is expected to grow and adapt to new challenges and opportunities.

Strategic Growth Opportunities for the Drug-Eluting Stent Market

The DES market is experiencing growth driven by various strategic opportunities in key applications. Identifying and leveraging these opportunities can lead to enhanced market presence and improved patient outcomes.

• Expansion into Emerging Markets: Emerging markets, such as Asia-Pacific and Latin America, present significant growth opportunities due to increasing cardiovascular disease prevalence and rising healthcare investments. Expanding market presence in these regions can drive revenue growth and increase access to advanced stent technologies.
• Development of Next-Generation Stents: Investment in next-generation DES with improved drug delivery systems, thinner struts, and biodegradable materials offers substantial growth potential. These innovations address current limitations and enhance the efficacy and safety of stent treatments, attracting both clinicians and patients.
• Integration of Digital Health Technologies: Incorporating digital health technologies, such as remote monitoring and data analytics, into DES treatment protocols can improve patient management and outcomes. These technologies enable better tracking of stent performance and patient compliance, leading to more effective treatments.
• Focus on Personalized Medicine: The growing emphasis on personalized medicine presents opportunities for developing customized DES solutions tailored to individual patient needs. By leveraging genetic and clinical data, manufacturers can create stents with optimized drug formulations and designs, enhancing treatment efficacy.
• Advancements in Imaging and Diagnostics: Integrating advanced imaging technologies, such as OCT and intravascular ultrasound, with DES can improve the precision of stent placement and deployment. These advancements allow for better assessment of vessel conditions and more accurate stent sizing, leading to improved patient outcomes.

Strategic growth opportunities in the DES market are driven by technological advancements, market expansion, and personalized approaches. By capitalizing on these opportunities, stakeholders can enhance their market position and contribute to improved patient care.

Drug-Eluting Stent Market Driver and Challenges

The DES market is shaped by a range of drivers and challenges that impact its growth trajectory. Technological advancements, economic factors, and regulatory issues play a crucial role in determining market dynamics and influencing stakeholder strategies.

The factors responsible for driving the drug-eluting stent market include:

• Technological Advancements: Innovations in stent technology, such as next-generation DES with improved drug delivery systems and biodegradable materials, are driving market growth. These advancements enhance the efficacy and safety of stents, leading to better patient outcomes and increased adoption.
• Growing Cardiovascular Disease Prevalence: The rising incidence of cardiovascular diseases globally is a significant driver for the DES market. Increasing patient numbers create a higher demand for effective treatment options, driving the growth of DES technologies.
• Regulatory Support and Innovation: Streamlined regulatory processes and support for innovative medical devices are facilitating faster approval and market entry for new DES technologies. This regulatory environment encourages ongoing research and development, driving market expansion.
• Rising Healthcare Expenditure: Increased healthcare spending and investment in advanced medical technologies are contributing to the growth of the DES market. Higher budgets for cardiovascular treatments enable the adoption of cutting-edge stent technologies.
• Growing Focus on Personalized Medicine: The emphasis on personalized medicine and tailored treatment approaches is driving innovation in DES. Customized stent designs and drug formulations based on individual patient profiles improve treatment outcomes and market demand.

Challenges in the drug-eluting stent market are:

• High Cost of Advanced DES: The high cost of advanced DES technologies can limit accessibility and affordability, particularly in emerging markets. This challenge affects market penetration and adoption rates, especially in cost-sensitive regions.
• Regulatory and Reimbursement Hurdles: Complex regulatory requirements and reimbursement issues can pose challenges for market entry and expansion. Navigating these hurdles requires significant resources and expertise, impacting the speed and ease of introducing new DES technologies.
• Competition and Market Saturation: The growing number of DES manufacturers and products can lead to market saturation and intensified competition. Differentiating products and maintaining market share amidst increasing competition can be challenging for companies.

Drivers such as technological advancements and growing cardiovascular disease prevalence are propelling the DES market forward. However, challenges like high costs and regulatory hurdles need to be addressed to ensure sustained growth and market development. Balancing these factors will be crucial for shaping the future of the DES market.

List of Drug-Eluting Stent Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, drug-eluting stent companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug-eluting stent companies profiled in this report include-

• Boston Scientific
• Medtronic
• Abbott Laboratories
• Biosensors
• Biotronik
• Lepu Medical Technology
• Terumo Medical
• Cook Medical
• Shandong JW Medical Systems
• B.Braun

Drug-Eluting Stent by Segment

The study includes a forecast for the global drug-eluting stent market by coating type, application, and region.

Drug-Eluting Stent Market by Coating Type [Analysis by Value from 2019 to 2031]:

• Polymer-Based Coating
• Polymer-Free Coating

Drug-Eluting Stent Market by Application [Analysis by Value from 2019 to 2031]:

• Coronary Artery Disease
• Peripheral Artery Disease

Drug-Eluting Stent Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Drug-Eluting Stent Market

The drug-eluting stent (DES) market has experienced significant advancements in recent years, driven by technological innovations, regulatory changes, and evolving patient needs. These developments are reshaping market dynamics across various countries. This summary provides an overview of recent trends and advancements in the DES market in the United States, China, Germany, India, and Japan.

• United States: In the U.S., recent advancements include the introduction of next-generation DES with enhanced biocompatibility and thinner struts, which reduce restenosis rates and improve patient outcomes. The FDA's streamlined approval process for innovative stent technologies has accelerated market entry. Additionally, there is a growing emphasis on personalized medicine, with stent designs tailored to specific patient demographics and conditions.
• China: China's DES market has seen rapid growth due to increasing cardiovascular disease prevalence and advancements in medical technology. Local manufacturers are investing heavily in research and development to produce cost-effective DES, leading to a rise in domestic production. Regulatory reforms have also facilitated faster approval of new DES technologies, boosting market growth.
• Germany: Germany remains a leader in the DES market in Europe, driven by its strong healthcare infrastructure and emphasis on advanced medical technologies. Recent developments include the adoption of biodegradable stents and innovations in drug delivery systems, which enhance the long-term safety and efficacy of DES. The German market also benefits from a robust reimbursement framework that supports the adoption of cutting-edge stent technologies.
• India: In India, the DES market is expanding due to increasing cardiovascular disease incidence and rising healthcare expenditure. Local and international companies are introducing affordable DES solutions to cater to the growing patient base. The Indian government's initiatives to improve healthcare access and infrastructure are also contributing to the market's growth.
• Japan: Japan's DES market is characterized by high adoption rates of advanced stent technologies and a focus on improving patient outcomes through innovation. Recent developments include the introduction of ultra-thin strut stents and advanced drug formulations. Japan's stringent regulatory standards ensure that only high-quality DES are approved, maintaining a high standard for patient care.

Features of the Global Drug-Eluting Stent Market

Market Size Estimates: Drug-eluting stent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Drug-eluting stent market size by coating type, application, and region in terms of value ($B).

Regional Analysis: Drug-eluting stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different coating types, applications, and regions for the drug-eluting stent market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the drug-eluting stent market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the drug-eluting stent market by coating type (polymer-based coating and polymer-free coating), application (coronary artery disease and peripheral artery disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug-Eluting Stent Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Drug-Eluting Stent Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Drug-Eluting Stent Market by Coating Type
  • 3.3.1: Polymer-Based Coating
  • 3.3.2: Polymer-Free Coating
• 3.4: Global Drug-Eluting Stent Market by Application
  • 3.4.1: Coronary Artery Disease
  • 3.4.2: Peripheral Artery Disease

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Drug-Eluting Stent Market by Region
• 4.2: North American Drug-Eluting Stent Market
  • 4.2.1: North American Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.2.2: North American Market by Application: Coronary Artery Disease and Peripheral Artery Disease
• 4.3: European Drug-Eluting Stent Market
  • 4.3.1: European Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.3.2: European Market by Application: Coronary Artery Disease and Peripheral Artery Disease
• 4.4: APAC Drug-Eluting Stent Market
  • 4.4.1: APAC Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.4.2: APAC Market by Application: Coronary Artery Disease and Peripheral Artery Disease
• 4.5: ROW Drug-Eluting Stent Market
  • 4.5.1: ROW Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
  • 4.5.2: ROW Market by Application: Coronary Artery Disease and Peripheral Artery Disease

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Drug-Eluting Stent Market by Coating Type
  • 6.1.2: Growth Opportunities for the Global Drug-Eluting Stent Market by Application
  • 6.1.3: Growth Opportunities for the Global Drug-Eluting Stent Market by Region
• 6.2: Emerging Trends in the Global Drug-Eluting Stent Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Drug-Eluting Stent Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug-Eluting Stent Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boston Scientific
• 7.2: Medtronic
• 7.3: Abbott Laboratories
• 7.4: Biosensors
• 7.5: Biotronik
• 7.6: Lepu Medical Technology
• 7.7: Terumo Medical
• 7.8: Cook Medical
• 7.9: Shandong JW Medical Systems
• 7.10: B.Braun